Bloomington, MN, United States of America

Ramkumar Moorthy

This inventor holds 1 USPTO granted patent. Top assignees: Regents of the University of Minnesota, University of California. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ramkumar Moorthy: Innovator in Cancer Treatment

Introduction

Ramkumar Moorthy is a notable inventor based in Bloomington, MN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.

Latest Patents

Moorthy holds a patent for "Compounds that degrade kinases and uses thereof." This patent is directed to compounds of the Formula (I) or (II): A-L-B, A'-L-B, or a pharmaceutically acceptable salt, polymorph, prodrug, solvate, or clathrate thereof. In this formula, A represents an Aurora A ligand, A' is a CDK4/6 ligand, B is an E3 ligase ligand, and L is a linker. The patent also includes pharmaceutical compositions comprising such compounds and methods for treating cancer using these compounds. He has 1 patent to his name.

Career Highlights

Throughout his career, Ramkumar Moorthy has worked with prestigious institutions such as the Regents of the University of Minnesota and the University of California. His work has focused on developing innovative solutions for cancer treatment, showcasing his dedication to advancing medical science.

Collaborations

Some of his notable coworkers include Daniel A Harki and Jian Tang. Their collaborative efforts have contributed to the success of various research projects and innovations in the field.

Conclusion

Ramkumar Moorthy's contributions to cancer treatment through his patented compounds highlight his role as an influential inventor. His work continues to inspire advancements in medical research and pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…